Science Explorer Back to mapMap
Discussion
Company · Newark · United States

Protagonist Therapeutics (United States)

protagonist-inc.comROR OpenAlex
Research works
59
◆ 1% vs 2018-21
Citations
202
3.4 per fractional work
Top-10% rate
13.6%
all institutions 10.0%
Open access
74%
world 40%
International
48%
world 18%
Protagonist Therapeutics (United States)

Not ranked overall: Protagonist Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Protagonist Therapeutics (United States) work in?

In 2022-now, 45% of research at Protagonist Therapeutics (United States) is in Health Sciences, 35% in Social Sciences. Its largest fields are Medicine (43%), Social Sciences (27%), Immunology and Microbiology (7%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 10 fractional works · 45.0% of its workMedicine: 9 fractional works · 43.5% of its workGenetics: 4 fractional works · 19.4% of its workHematology: 2 fractional works · 7.9% of its workInfectious Diseases: 0 fractional works · 2.4% of its workOncology: 0 fractional works · 2.2% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.8% of its workEpidemiology: 0 fractional works · 1.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.4% of its workSurgery: 0 fractional works · 1.3% of its workPhysiology: 0 fractional works · 1.3% of its workRheumatology: 0 fractional works · 1.2% of its workGeriatrics and Gerontology: 0 fractional works · 0.8% of its workDermatology: 0 fractional works · 0.5% of its workObstetrics and Gynecology: 0 fractional works · 0.5% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workHealth Professions: 0 fractional works · 1.3% of its workGeneral Health Professions: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.2% of its workSocial Sciences: 7 fractional works · 34.6% of its workSocial Sciences: 6 fractional works · 27.0% of its workSociology and Political Science: 2 fractional works · 8.7% of its workUrban Studies: 1 fractional works · 6.2% of its workEducation: 1 fractional works · 4.5% of its workDemography: 1 fractional works · 3.9% of its workPolitical Science and International Relations: 0 fractional works · 1.6% of its workGender Studies: 0 fractional works · 1.0% of its workLaw: 0 fractional works · 0.6% of its workAnthropology: 0 fractional works · 0.5% of its workArts and Humanities: 1 fractional works · 6.3% of its workPhilosophy: 1 fractional works · 2.6% of its workLiterature and Literary Theory: 0 fractional works · 1.6% of its workConservation: 0 fractional works · 0.6% of its workHistory: 0 fractional works · 0.6% of its workGeneral Arts and Humanities: 0 fractional works · 0.5% of its workMuseology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPsychology: 0 fractional works · 0.9% of its workSocial Psychology: 0 fractional works · 0.7% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.4% of its workInformation Systems and Management: 0 fractional works · 0.4% of its workLife Sciences: 2 fractional works · 11.1% of its workImmunology and Microbiology: 2 fractional works · 7.3% of its workImmunology: 1 fractional works · 6.5% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.8% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.6% of its workPharmacology: 0 fractional works · 1.6% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 1.5% of its workMolecular Medicine: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workForestry: 0 fractional works · 0.8% of its workPhysical Sciences: 2 fractional works · 9.3% of its workEngineering: 1 fractional works · 5.8% of its workBuilding and Construction: 0 fractional works · 2.4% of its workBiomedical Engineering: 0 fractional works · 1.6% of its workMechanical Engineering: 0 fractional works · 1.6% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 1.6% of its workInformation Systems: 0 fractional works · 1.0% of its workArtificial Intelligence: 0 fractional works · 0.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 1.6% of its workSpectroscopy: 0 fractional works · 1.6% of its workEnvironmental Science: 0 fractional works · 0.3% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.3% of its workALL ITS WORKProtagonistTherapeutics…21fractional works, 2022-now
Life Sciences11%Physical Sciences9%Health Sciences45%Social Sciences35%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine943.5%
    2. Health Professions01.3%
    3. Nursing00.2%
    1. Social Sciences627.0%
    2. Arts and Humanities16.3%
    3. Psychology00.9%
    4. Decision Sciences00.4%
    1. Immunology and Microbiology27.3%
    2. Pharmacology, Toxicology and Pharmaceutics01.6%
    3. Biochemistry, Genetics and Molecular Biology01.5%
    4. Agricultural and Biological Sciences00.8%
    1. Engineering15.8%
    2. Computer Science01.6%
    3. Chemistry01.6%
    4. Environmental Science00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.17× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.27× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 7.24× its world share, 2 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 4.48× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.01× its world share, 0 worksChemistryComputer Science: 0.21× its world share, 0 worksComputer ScienceEngineering: 0.39× its world share, 1 worksEngineeringEnvironmental Science: 0.05× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.49× its world share, 0 worksHealth ProfessionsMedicine: 2.26× its world share, 9 worksMedicineNursing: 0.40× its world share, 0 worksNursingArts and Humanities: 2.20× its world share, 1 worksArts and HumanitiesDecision Sciences: 0.41× its world share, 0 worksDecision SciencesPsychology: 0.31× its world share, 0 worksPsychologySocial Sciences: 2.13× its world share, 6 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.2×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Immunology and Microbiology7.24×2 works
  2. Pharmacology, Toxicology and Pharmaceutics4.48×0 works
  3. Medicine2.26×9 works
  4. Arts and Humanities2.20×1 works
  5. Social Sciences2.13×6 works
  6. Chemistry1.01×0 works
  7. Health Professions0.49×0 works
  8. Decision Sciences0.41×0 works
  9. Nursing0.40×0 works
  10. Engineering0.39×1 works
  11. Psychology0.31×0 works
  12. Biochemistry, Genetics and Molecular Biology0.27×0 works
  13. Computer Science0.21×0 works
  14. Agricultural and Biological Sciences0.17×0 works
  15. Environmental Science0.05×0 works

Who are the top researchers at Protagonist Therapeutics (United States)?

Ranked on the quality score, Suneel Gupta, Nishit B. Modi and Larry C. Mattheakis lead among researchers whose main affiliation is Protagonist Therapeutics (United States).

  1. 1 Suneel Gupta United States · #1,161,473 worldwide 4.6k citations · 149 works
  2. 2 Nishit B. Modi United States · #1,256,624 worldwide 3.7k citations · 120 works
  3. 3 Larry C. Mattheakis United States · #2,249,083 worldwide 2k citations · 75 works
  4. 4 Thamil Annamalai United States · #3,742,801 worldwide 289 citations · 16 works
  5. 5 James Tovera United States · #4,479,990 worldwide 184 citations · 18 works
  6. 6 Rose Neubauer United States · #4,566,882 worldwide 33 citations · 18 works
  7. 7 Xiaoli Cheng United States · #5,119,470 worldwide 326 citations · 45 works
  8. 8 Aurelija Mykolaitytė United States · #5,522,561 worldwide 5 citations · 45 works
  9. 9 Bai Lu United States · #6,292,033 worldwide 205 citations · 84 works
All ranked researchers at Protagonist Therapeutics (United States)

What are the most cited papers from Protagonist Therapeutics (United States)?

The most cited paper from Protagonist Therapeutics (United States) is "Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo" (Sheila H. Ranganath et al., 2015), with 44 citations. Next come "JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans" (42) and "Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial" (40).

Most cited papers
#PaperReleasedCitations
1 Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo Sheila H. Ranganath et al. · PLoS ONE Open access 10 Nov 2015 44
2 JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans Anne M. Fourie et al. · Scientific Reports Open access 30 Jul 2024 42
3 Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial Kris V. Kowdley, Nishit B. Modi, Kevork Minas Peltekian et al. · ˜The œLancet. Gastroenterology & hepatology 17 Oct 2023 40
4 PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis William J. Sandborn, Larry C. Mattheakis, Nishit B. Modi et al. · Gastroenterology Open access 30 Aug 2021 37
5 Preclinical Serological Signatures are Associated With Complicated Crohn’s Disease Phenotype at Diagnosis Rok Seon Choung, Francesca Petralia, Joana Torres et al. · Clinical Gastroenterology and Hepatology Open access 12 Feb 2023 29
All 88 most cited papers, with filters and sorting

Which keywords describe research at Protagonist Therapeutics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: JAK2 Mutation, Myelofibrosis, Pulmonary Hypertension, Public Policy, Sickle-cell Disease, Thalassemia, Epidemiology and Globalization.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Epidemiology3▲ 3.2×8 topics
  2. JAK2 Mutation2▲ 466×1 topic
  3. Myelofibrosis2▲ 466×1 topic
  4. Globalization2▲ 5.0×5 topics
  5. Public Policy2▲ 19×4 topics
  6. Pulmonary Hypertension2▲ 67×2 topics
  7. Sickle-cell Disease2▲ 204×1 topic
  8. Thalassemia2▲ 204×1 topic
  9. Social Movements2▲ 24×5 topics
  10. Colonialism1▲ 14×5 topics
  11. Inflammation1▲ 3.1×8 topics
  12. Territoriality1▲ 132×2 topics
  13. Sustainability1▲ 2.3×2 topics
  14. Pandemic1▲ 5.3×4 topics
  15. Segregation1▲ 71×1 topic
  16. Urbanization1▲ 13×1 topic

Which research topics does Protagonist Therapeutics (United States) publish most on?

By volume in 2022-now: Myeloproliferative Neoplasms: Diagnosis and Treatment, Hemoglobinopathies and Related Disorders, Urban Development and Societal Issues and Iron Metabolism and Disorders.

Myeloproliferative Neopl…2Myeloproliferative Neoplasms: Diagnosis and Treatment: 2 fractional worksHemoglobinopathies and R…2Hemoglobinopathies and Related Disorders: 2 fractional worksUrban Development and Societal Issues: 1 fractional worksIron Metabolism and Disorders: 1 fractional worksSMEs Development and Digital Marketing: 0 fractional worksUrban Design and Spatial Analysis: 0 fractional worksAcute Myeloid Leukemia Research: 0 fractional worksCultural, Media, and Literary Studies: 0 fractional worksPsoriasis: Treatment and Pathogenesis: 0 fractional worksComplement system in diseases: 0 fractional works
GeneticsUrban StudiesHematologyDemography3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
  2. 2 Hemoglobinopathies and Related Disorders Genetics 2 works
  3. 3 Urban Development and Societal Issues Urban Studies 1 works
  4. 4 Iron Metabolism and Disorders Hematology 1 works
  5. 5 SMEs Development and Digital Marketing Demography 0 works
  6. 6 Urban Design and Spatial Analysis Building and Construction 0 works
  7. 7 Acute Myeloid Leukemia Research Hematology 0 works
  8. 8 Cultural, Media, and Literary Studies Philosophy 0 works
  9. 9 Psoriasis: Treatment and Pathogenesis Immunology 0 works
  10. 10 Complement system in diseases Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available73.9%not open26.1%

World: 40% of research is openly available.

with international co-authors47.7%domestic only52.3%

World: 18% is written across borders.

How has Protagonist Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 1% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Protagonist Therapeutics (United States) as a percentage of every work published that year, 0.00012% in 2024.

still counting0.000050%0.00010%0.00015%Protagonist Therapeutics (United States)0.000047% in 20251990200020102020

Fractional works of Protagonist Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Newark

All research institutions in Newark

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Protagonist Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.